Screening Procedure. 28.6.1 The initial screening of all collected specimens will be conducted by a designated Substance Abuse and Mental Health Services Association (SAMHSA) certified laboratory. This will generally occur within forty-eight (48) hours of receipt of the specimen.
28.6.2 Initial screening of urine specimens will be conducted using a testing methodology based primarily upon an “Enzyme Immunoassay” or other testing methodology of equivalent quality and acceptability.
28.6.3 If a confirmation test is conducted, it will be conducted by Gas Chromatography/Mass Spectrometry (GC/MS) testing or other testing methodology of equivalent quality and acceptability.
28.6.4 Upon receipt of a specimen for testing, the designated Laboratory will:
28.6.4.1 Check the container to ensure it is not damaged, and that the seal is intact. If the seal is broken or the container damaged, the lab notifies the collection facility. The result will be considered a test taken and a negative result.
28.6.4.2 Complete the appropriate “chain-of-custody” for the specimen.
28.6.4.3 Conduct the initial testing of the specimen using an "Enzyme Immunoassay" technique or other testing methodology of equivalent quality and acceptability.
28.6.4.4 If the specimen tests “negative," all urine specimens will be discarded.
28.6.4.5 If the specimen tests "positive," a confirmation test will be performed for the specific drug(s) found in the specimen during the initial test.
28.6.4.6 If the confirmation test confirms the presence of drugs, any remainder of the “A” specimen and the “B” specimen will be retained in a locked freezer for a minimum of one (1) year.
28.6.4.7 If the confirmation test is “negative” the whole test will be considered negative.
Screening Procedure. 1. The screening of all collected samples will be conducted within forty-eight 48 hours by a City-designated laboratory certified by the Substance Abuse and Mental Health Services Administration (SAMHSA).
2. Initial screening of urine samples will be conducted using a testing methodology such as the “Enzyme Immunoassay” or other technique.
3. If a confirmation test is required, it will be conducted by Gas Chromatography/Mass Spectrometry (GC/MS) or other testing methodology of equivalent quality and acceptability.
4. Upon receipt of the samples for testing, the designated laboratory will:
a. Check the containers to ensure they are not damaged, and that the seals are intact.
b. Complete the appropriate chain of custody forms for the samples.
c. Conduct the initial testing of one of the samples using the “Enzyme Immunoassay” or other technique.
d. If the sample tests “negative,” all urine samples will be discarded.
e. If the urine sample tests “positive,” a confirmation test will be conducted.
1. The confirmation test will be determined by the specific drug found in the sample during the initial test.
2. The confirmation test will be conducted using the GC/MS or other alternative technique.
f. If the confirmation test confirms the presence of drugs, both samples will be retained in a locked freezer for a minimum of one year.
g. If the confirmation test is “negative,” the whole test will be considered negative and all urine samples will be destroyed.
Screening Procedure. 1. Phase I - Paper screening by the Human Resources Department (credential/teaching eligibility).
2. Phase II - Oral interview by the site administrator or the site screening panel. Each site Screening Panel shall include:
a. Building Principal or designee
b. Assistant Principal or other administrator
c. Two (2) teachers from the department, neither of whom is/was an applicant for the position. Prior to the final selection, the following criteria shall be considered when filling the position:
(a) Credential authorization;
(b) Major or minor field of study;
(c) Educational goals of the District;
(d) Most recent overall evaluation (satisfactory or better);
(e) All assignments shall be made on the basis of the best possible educational program for the students;
(f) Impact on the teaching schedule of other unit members; and,
Screening Procedure. A. The screening of all collected samples will be conducted within 48 hours by a City designated laboratory certified by the National Institute on Drug Abuse (NIDA).
B. Initial screening of urine samples will conducted using a testing methodology such as the “Enzyme Immunoassay” or other technique.
C. If a confirmation test is required, it will conducted by Gas Chromatography/Mass Spectrometry (GC/MS) or other testing methodology of equivalent quality and acceptability.
D. Upon receipt of the samples for testing, the designated Laboratory Technician will:
1. Check the containers to ensure they are not damaged, and that the seals are intact.
2. Complete the appropriate chain of custody forms for the samples.
3. Conduct the initial testing of one of the samples using the “Enzyme Immunoassay” or other technique.
4. If the sample tests “negative”, all urine samples will be discarded.
5. If the urine sample tests “positive”, a confirmation test will be conducted.
a. The confirmation test will be determined by the specific drug found in the sample during the initial test.
b. The confirmation test will be conducted using the GC/MS or other alternative technique.
6. If the confirmation test confirms the presence of drugs, both samples will be retained in a locked freezer for a minimum of one year.
7. If the confirmation test is “negative”, the whole test will be considered negative.
Screening Procedure. Position openings will be posted on various employment networking websites. Potential applicants will be screened through a two‐step interview process. The first interview will be scheduled with the Orange County Program Director of Year Round Emergency Shelter Program, Services, and Outreach as well as the Program Manager of Year Round Emergency Shelter Program and Services. If deemed eligible, the applicant will conduct an interview with the Executive Director and Operations Director of the agency.
Screening Procedure. The Employer acknowledges an obligation to maintain on payroll regular employees who have completed their probationary period and who, through advancing years or temporary disablement, are unable to perform their regular duties, and to all employees who have become incapacitated by industrial injury or industrial illness. The Screening Committee shall be a sub-committee of the Labour Management Committee. The Screening Committee shall be comprised of one (1) Employer representative appointed by the Employer and one (1) Union representative appointed by the Union. The Screening Committee shall report its activities to the Labour Management Committee. Information provided by the employees to the Screening Committee shall remain confidential and strictly for the use of the Committee. The Committee may make recommendations to the Institute to retrain the employee in a less arduous position and/or to recommend what retraining the Committee deems advisable. The Screening Committee shall develop operating procedures which shall be mutually agreed on by the Parties.
Screening Procedure. All positive results of initial screening shall be subjected to a GC/MS confirmatory test.
Screening Procedure. 1. The initial screening of all collected samples will generally be conducted within forty-eight (48) hours of receipt by a City-designated Laboratory certified by the Substance Abuse and Mental Health Services Administration (SAMHSA).
2. Initial screening of urine samples will be conducted using a testing methodology based primarily upon an “Enzyme Immunoassay” or other testing methodology of equivalent quality and acceptability.
3. If a confirmation test is required, it will be conducted by Gas Chromatography/Mass Spectrometry (GC/MS) testing or other testing methodology of equivalent quality and acceptability.
4. Upon receipt of a sample for testing, the designated laboratory will:
a. Check the container to ensure it is not damaged, and that the seal is intact.
b. Complete the appropriate chain-of-custody forms for the sample.
c. Conduct the initial testing of the sample using an “Enzyme Immunoassay” technique or other testing methodology of equivalent quality and acceptability.
d. If the sample tests “negative,” all urine samples will be discarded.
e. If the sample tests “positive,” a confirmation test will be performed for the specific drug or drugs found in the sample during the initial test.
f. If the confirmation test confirms the presence of drugs, any remainder of the test sample and the entire control sample will be retained in a locked freezer for a minimum of one (1) year.
g. If the confirmation test is “negative,” the whole test will be considered negative and all urine samples will be destroyed.
Screening Procedure. The following screening questions have been put in place to ensure the safety of all involved parties at the Chamber Fall Trade Fair: • If you have travelled internationally within 14 days of the scheduled event date you will NOT be permitted to attend. • If you are symptomatic and waiting on a laboratory result for COVID-19 on the scheduled event date you will NOT be permitted to attend. • If you have been identified as someone who has been tested positive for COVID-19 or has been asked to self-isolate by AHS on the scheduled event date you are NOT permitted to attend. If anyone working in your booth is presenting any of the following symptoms for COVID- 19 on the date of the event they will NOT be permitted to attend: • Fever • New cough or worsening chronic cough • New or worsening shortness of breath or difficulty breathing • Sore throat • Runny nose
Screening Procedure. Position openings will be posted on various employment networking websites. Potential applicants will be screened through a two-step interview process. The first interview will be scheduled with the Orange County Program Director of Costa Mesa Bridge Shelter Program, Services, and Outreach as well as the Program Manager of Costa Mesa Bridge Shelter and Services. If deemed eligible, the applicant will conduct an interview with the Executive Director and Operations Director of the agency.
